| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bending the Arc
|
Burki, Talha Khan
|
|
2017
|
5 |
4 |
p. 258-
1 p.
|
artikel
|
| 2 |
Clinical trial research in focus: overcoming barriers in MDR-TB clinical trials
|
Zumla, Alimuddin
|
|
2017
|
5 |
4 |
p. 247-248
2 p.
|
artikel
|
| 3 |
Congestion of the streets and lungs in India
|
Cavanaugh, Ray
|
|
2017
|
5 |
4 |
p. 253-254
2 p.
|
artikel
|
| 4 |
C-Tb: a latent tuberculosis skin test for the 21st century?
|
Abubakar, Ibrahim
|
|
2017
|
5 |
4 |
p. 236-237
2 p.
|
artikel
|
| 5 |
Drug-resistant tuberculosis in 2017: at a crossroads
|
Dowdy, David W
|
|
2017
|
5 |
4 |
p. 241-242
2 p.
|
artikel
|
| 6 |
EC proposes tightening carcinogen regulations
|
Burki, Talha Khan
|
|
2017
|
5 |
4 |
p. 251-
1 p.
|
artikel
|
| 7 |
Florence Seibert
|
Harding, Emilia
|
|
2017
|
5 |
4 |
p. 255-256
2 p.
|
artikel
|
| 8 |
From latent to patent: rethinking prediction of tuberculosis
|
Cobelens, Frank
|
|
2017
|
5 |
4 |
p. 243-244
2 p.
|
artikel
|
| 9 |
Health inequality: a major driver of respiratory disease
|
The Lancet Respiratory Medicine,
|
|
2017
|
5 |
4 |
p. 235-
1 p.
|
artikel
|
| 10 |
Landmark legal ruling sees Indian girl prescribed bedaquiline for XDR-TB
|
Kirby, Tony
|
|
2017
|
5 |
4 |
p. 249-
1 p.
|
artikel
|
| 11 |
Management of extensively drug-resistant tuberculosis
|
Centis, Rosella
|
|
2017
|
5 |
4 |
p. 237-239
3 p.
|
artikel
|
| 12 |
Osimertinib improves progression-free survival in NSCLC
|
Pinion, Sheila
|
|
2017
|
5 |
4 |
p. 251-
1 p.
|
artikel
|
| 13 |
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study
|
Dheda, Keertan
|
|
2017
|
5 |
4 |
p. 269-281
13 p.
|
artikel
|
| 14 |
Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial
|
Ruhwald, Morten
|
|
2017
|
5 |
4 |
p. 259-268
10 p.
|
artikel
|
| 15 |
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study
|
Andrews, Jason R
|
|
2017
|
5 |
4 |
p. 282-290
9 p.
|
artikel
|
| 16 |
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
|
Dheda, Keertan
|
|
2017
|
5 |
4 |
p. 291-360
70 p.
|
artikel
|
| 17 |
The time has come: sparing injectables in paediatric MDR-TB
|
Weld, Ethel D
|
|
2017
|
5 |
4 |
p. 245-246
2 p.
|
artikel
|
| 18 |
The uncertain science of predicting tuberculosis
|
Togun, Toyin
|
|
2017
|
5 |
4 |
p. 239-240
2 p.
|
artikel
|
| 19 |
The uphill battle to find new TB treatments
|
Burki, Talha Khan
|
|
2017
|
5 |
4 |
p. 250-
1 p.
|
artikel
|
| 20 |
The war on tuberculosis must continue
|
Grainger, Emma
|
|
2017
|
5 |
4 |
p. 241-
1 p.
|
artikel
|
| 21 |
Tuberculosis missing from WHO bacteria list
|
Burki, Talha Khan
|
|
2017
|
5 |
4 |
p. 252-
1 p.
|
artikel
|
| 22 |
Will we ever eliminate tuberculosis, the voiceless disease?
|
Tanday, Sanjay
|
|
2017
|
5 |
4 |
p. 256-257
2 p.
|
artikel
|
Tijdschrift beschrijving